Ezetimib-Simvastatin-Mepha Teva
Ezetimib-Simvastatin-Mepha Teva is a generic from Mepha Pharma AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 30.15 to CHF 94.25 depending on the pack; the co-payment is 10 per cent.
Core data
- Authorisation holder
- Mepha Pharma AG
- ATC code
- C10BA02
- IT group
- 07.12 Blutlipidsenkende Mittel
- Active substances
- Ezetimibum, Simvastatinum
- Preparation type
- Generic
- On the SL since
- 01/07/2023
- Last price change
- 01/07/2023
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Tabl 10/10 mg | Blist 28 Stk | CHF 12.62 | CHF 30.15 | 01/07/2023 | B | 7680670740104 |
| Tabl 10/10 mg | Blist 98 Stk | CHF 44.04 | CHF 64.30 | 01/07/2023 | B | 7680670740111 |
| Tabl 10/20 mg | Blist 28 Stk | CHF 14.22 | CHF 31.90 | 01/07/2023 | B | 7680670740128 |
| Tabl 10/20 mg | Blist 98 Stk | CHF 49.63 | CHF 70.40 | 01/07/2023 | B | 7680670740135 |
| Tabl 10/40 mg | Blist 28 Stk | CHF 16.56 | CHF 34.45 | 01/07/2023 | B | 7680670740142 |
| Tabl 10/40 mg | Blist 100 Stk | CHF 58.34 | CHF 79.85 | 01/07/2023 | B | 7680670740159 |
| Tabl 10/80 mg | Blist 28 Stk | CHF 20.06 | CHF 38.25 | 01/07/2023 | B | 7680670740166 |
| Tabl 10/80 mg | Blist 100 Stk | CHF 71.59 | CHF 94.25 | 01/07/2023 | B | 7680670740173 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Die Vergütung einer neuverschriebenen EZETIMIB-SIMVASTATIN-MEPHA-TEVA-Therapie ist zudem möglich bei:
- Patienten mit hohem Risiko gemäss AGLA-Risikokategorie, die Atorvastatin und Rosuvastatin nicht vertragen und den LDL-Zielwert - Patienten mit sehr hohem Risiko gemäss AGLA-Risikokategorie, die Atorvastatin und Rosuvastatin nicht vertragen und den LDL-Zielwert - Patienten mit Statin-Intoleranz, d.h. Patienten, die bei Einnahme eines Statins nicht tolerierbare Muskelschmerzen und/oder messbare Muskelschwäche und/oder eine Erhöhung der Creatininkinase >5x des oberen Grenzwertes aufweisen. Vor der Verschreibung von EZETIMIB-SIMVASTATIN-MEPHA TEVA ist ein anderes Statin und, sofern dies nicht vertragen wird, Atorvastatin oder Rosuvastatin 5-10 mg 1-2x pro Woche auszuprobieren.
More preparations in this group
FAQ
Is Ezetimib-Simvastatin-Mepha Teva covered by Swiss health insurance?
Yes, but only under conditions. Ezetimib-Simvastatin-Mepha Teva is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Ezetimib-Simvastatin-Mepha Teva cost in Switzerland?
The public price is the maximum price set by the FOPH and for Ezetimib-Simvastatin-Mepha Teva ranges from CHF 30.15 to CHF 94.25 per pack. The ex-factory price ranges from CHF 12.62 to CHF 71.59. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages